The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors

por Ko, Tun Kiat, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Ong, S. Tiong
Publicado 2014

The BIM deletion polymorphism: A paradigm of a permissive interaction between germline and acquired TKI resistance factors in chronic myeloid leukemia

por Ko, Tun Kiat, Chin, Hui San, Chuah, Charles T.H., Huang, John W.J., Ng, King-Pan, Khaw, Seong Lin, Huang, David C.S., Ong, S. Tiong
Publicado 2015

The arginase inhibitor N(ω)−hydroxy−nor−arginine (nor−NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as...

por Ng, King Pan, Manjeri, Aditi, Lee, Lin Ming, Chan, Zhu En, Tan, Chin Yee, Tan, Qiancheng Darren, Majeed, A'Qilah, Lee, Kian Leong, Chuah, Charles, Suda, Toshio, Ong, S. Tiong
Publicado 2018

Rapid production of clinical‐grade SARS‐CoV‐2 specific T cells

por Leung, Wing, Soh, Teck Guan, Linn, Yeh Ching, Low, Jenny Guek‐Hong, Loh, Jiashen, Chan, Marieta, Chng, Wee Joo, Koh, Liang Piu, Poon, Michelle Li‐Mei, Ng, King Pan, Kuick, Chik Hong, Tan, Thuan Tong, Tan, Lip Kun, Seng, Michaela Su‐fern
Publicado 2020